Cognizant Technology Solutions Corp CTSH
We take great care to ensure that the data presented and summarized in this overview for COGNIZANT TECHNOLOGY SOLUTIONS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CTSH
View all-
Vanguard Group Inc Valley Forge, PA58.2MShares$4.4 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY53MShares$4.01 Billion0.08% of portfolio
-
State Street Corp Boston, MA24.1MShares$1.82 Billion0.07% of portfolio
-
Richard Pzena Pzena Investment Management LLC18.6MShares$1.41 Billion4.51% of portfolio
-
Dodge & Cox San Francisco, CA18.5MShares$1.39 Billion0.79% of portfolio
-
Nomura Holdings Inc Tokyo, M013.7MShares$1.04 Billion1.85% of portfolio
-
Geode Capital Management, LLC Boston, MA13.1MShares$990 Million0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY12.9MShares$976 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA10.8MShares$819 Million0.16% of portfolio
-
First Trust Advisors LP Wheaton, IL9.03MShares$682 Million0.65% of portfolio
Latest Institutional Activity in CTSH
Top Purchases
Top Sells
About CTSH
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.
Insider Transactions at CTSH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2024
|
Kathryn Diaz EVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-1.25%
|
$13,832
$76.09 P/Share
|
Oct 01
2024
|
Kathryn Diaz EVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
367
+2.45%
|
-
|
Oct 01
2024
|
Surya Gummadi EVP and President, Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.54%
|
$13,756
$76.09 P/Share
|
Oct 01
2024
|
Surya Gummadi EVP and President, Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
367
+1.09%
|
-
|
Sep 06
2024
|
Kathryn Diaz EVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-3.21%
|
$35,400
$75.84 P/Share
|
Sep 06
2024
|
Kathryn Diaz EVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+5.98%
|
-
|
Sep 04
2024
|
Jatin P Dalal Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,846
-22.07%
|
$296,142
$77.32 P/Share
|
Sep 04
2024
|
Jatin P Dalal Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,020
+18.47%
|
-
|
Sep 03
2024
|
Kathryn Diaz EVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-2.95%
|
$32,186
$77.77 P/Share
|
Sep 03
2024
|
Ravi Kumar Singisetti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,918
-5.37%
|
$224,686
$77.77 P/Share
|
Sep 03
2024
|
Jatin P Dalal Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,080
-9.4%
|
$83,160
$77.77 P/Share
|
Sep 03
2024
|
Robert Telesmanic SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-1.83%
|
$44,044
$77.77 P/Share
|
Sep 03
2024
|
John Sunshin Kim EVP, CLO, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,919
-4.45%
|
$147,763
$77.77 P/Share
|
Sep 03
2024
|
Surya Gummadi EVP and President, Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
1,347
-3.94%
|
$103,719
$77.77 P/Share
|
Sep 01
2024
|
Kathryn Diaz EVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,034
+3.55%
|
-
|
Sep 01
2024
|
Ravi Kumar Singisetti Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,309
+8.89%
|
-
|
Sep 01
2024
|
Jatin P Dalal Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+14.6%
|
-
|
Sep 01
2024
|
Robert Telesmanic SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
932
+1.48%
|
-
|
Sep 01
2024
|
John Sunshin Kim EVP, CLO, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,508
+2.71%
|
-
|
Sep 01
2024
|
Balu Ganesh Ayyar EVP and President IOA |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.61%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 230K shares |
---|---|
Grant, award, or other acquisition | 2.74K shares |
Payment of exercise price or tax liability | 87.8K shares |
---|---|
Open market or private sale | 17.6K shares |